Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS

Gene Therapy

Volumn 4, Issue 11, 1997, Pages 1216-1224

  Manca, F ^a,b   Fenoglio, D ^a,b   Franchin, E ^c   Saverino, D ^b   Li Pira, G ^b   Buffa, F ^b   Bignardi, D ^d   Del Pup, L ^c   Palu G ^c,e  

^a UNIVERSITY OF GENOA   (Italy)

^b ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Adoptive immunotherapy; Antigen specific CD4 cells; Opportunistic infections

Indexed keywords

CD4 ANTIGEN; COMPLEMENTARY DNA; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSDUCTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SUPERINFECTION; T LYMPHOCYTE; VIRUS REPLICATION;

CANDIDA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030864267     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300539     Document Type: Article

References (61)

1. Kornfeld H, Van de Stowue M, Reddy MM, Grieco MH. T-lymphocyte subpopulations in homosexual men. New Engl J Med 1982; 307: 729-731
2. Fahey JL et al. Quantitative changes in T helper or T suppressor cytotoxic lymphocyte subsets that distinguish acquired immunodeficiency syndrome from other immune subset disorders. Am J Med 1984; 76: 95-100.
3. Koenig S, Fauci AS. AIDS: immunopathogenesis and immune response to the human immunodeficiency virus. In: De Vita TJ, Hellman S, Rosenberg SA (eds). AIDS, Etiology, Diagnosis, Treatment and Prevention. JB Lippincott Co: Philadelphia, 1992, pp 61-77.
4. Heeney JL. AIDS: a disease of impaired Th cell renewal? Immunol Today 1995; 16: 515-520.
5. Miedema F, Klein MR. AIDS pathogenesis: a finite immune response to blame? Science 1996; 272: 505-506.
6. Zinkernagel RM, Hengartner H T cell mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 1994; 15: 262-268.
7. Kovacs JA, Masur H. Opportunistic infections. In: De Vita TJ, Hellman S, Rosenberg SA (eds). AIDS, Etiology, Diagnosis, Treatment and Prevention. JB Lippincott Co: Philadelphia, 1992, pp 199-225.
8. Kauffman SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993; 11: 129-163.
9. Mosmann TR, Coffman RL. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
10. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell derived cytokines. Annu Rev Immunol 1992; 10: 385-409.
11. Stuhler G, Walden P. Collaboration of helper and cytotoxic T lymphocytes. Eur J Immunol 1993; 23: 2279-2284.
12. + cytotoxic T cell responses during chronic viral infection. J Virol 1994; 68: 8056-8063.
13. + T lymphocyte lines from HIV-1 seropositive patients. J Infect Dis 1995; 171: 1420-1430.
14. Riddell SR, Greenberg PD. Principles for adoptive T cell therapy of human viral diseases. Annu Rev Immunol 1995; 13: 545-586.
15. Heslop HE et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med 1996; 2: 551-555.
16. Rooney CM et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus related lymphoproliferation. Lancet 1995; 345: 9-13.
17. Zack JA et al. HIV entry into quiescent primary lymphocytes: molecular analysis reveals a labile latent viral structure. Cell 1990; 61: 213-222
18. Staprans Sl et al. Activation of virus replication after vaccination of HIV infected individuals. J Exp Med 1995; 182: 1727-1737.
19. O'Brien WA et al. HIV-1 replication can be increased in peripheral blood of seropositive patients following influenza vaccination. Blood 1995; 86: 1082-1089.
20. Biasiolo MA et al. A new antisense tRNA construct for genetic treatment of human immunodeficiency virus type 1 infection. J Virol 1996; 70: 2154-2161.
21. Manca F et al. Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies. Eur J Immunol 1996; 25: 1217-1223.
22. Maggi E et al. Profiles of lymphokine activities and helper function for IgE in human T cell clones. Eur J Immunol 1988; 18: 1045-1050.
23. Street NE et al. Heterogeneity of mouse T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of TH1 and Th2 cells. J Immunol 1990; 144: 1629-1639.
24. Myers G et al. Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory: Los Alamos, NM, 1993.
25. Yu M, Poeschla E, Wong Staal F. Towards gene therapy for HIV infection. Gene Therapy 1994; 1: 13-26.
26. Palù G. Combined strategies for gene therapy of AIDS. Gene Therapy 1997; 4: 179-180.
27. Lo KMS et al. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat nbozyme RNA. Virology 1992; 190: 176-183.
28. Yu M et al. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993; 90: 6340-6344.
29. Rhodes A, James W. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol 1990; 71: 1965-1974.
30. + T lymphocytes. Hum Gene Ther 1994; 5: 193-201.
31. + hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in mielomonocytic cells produced in long-term culture. J Virol 1996; 70: 4352-4361.
32. Sun LQ et al. Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense or polymeric trans-activation response element constructs. Proc Natl Acad Sci USA 1995; 92: 7272-7276.
33. Lisziewicz J, Sun D, Liszievicz A, Gallo RC. Antitat gene therapy: a candidate for late-stage AIDS patients. Gene Therapy 1993; 2: 218-222.
34. Vandendriessche T et al. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4 T lymphocytes by retroviral vectors expressing anti-HIV genes. J Virol 1995; 69: 4045-4052.
35. Woffendin C et al. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus infected patients. Proc Natl Acad Sci USA 1996; 93: 2889-2894.
36. Federico M et al. A non producer interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse-human pseudotype. J Virol 1995; 69: 6618-6626.
37. Leavitt MC et al. Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. Hum Gene Ther 1994; 5: 1115-1120.
38. Woffendin C et al. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc Natl Acad Sci USA 1994; 91: 11581-11585.
39. + cells in vitro Nature Med 1996; 2: 46-51.
40. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272: 54-60.
41. Yamada O et al. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev responsive element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1. J Virol 1996; 70: 1596-1601.
42. Mavilio F et al. Peripheral blood lymphocytes as targets of retroviral vector-mediated gene transfer. Blood 1994; 83: 1988-1997.
43. Chesnut JD et al. Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody. J Immunol Meth 1996; 193: 17-27.
44. Riddell SR et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med 1996; 2: 216-223.
45. Katz RA, Skalka AN. The retroviral enzymes. Annu Rev Biochem 1994; 63: 133-173.
46. Corey L, Holmes KK. Therapy for human immunodeficiency virus infection. What have we learned? New Engl J Med 1996; 335: 1142-1144.
47. Cohen J. Results on new AIDS drugs bring cautious optimism. Science 1996; 271: 755-756.
48. Wei X et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122.
49. Ho DD et al. Rapid turnover of plasma virions and CD4 lympho-cytes in HIV-1 infection. Nature 1995; 373: 123-126.
50. Walter EA et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New Engl J Med 1995; 333: 1038-1044.
51. Manca F, Habeshaw JA, Dalgleish AG. HIV envelope glycoprotein, antigen-specific T cell response and soluble CD4. Lancet 1990; 335: 811-815.
52. Manca F et al. Effect of antigen/antibody ratio on macrophage uptake, processing and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med 1991; 173: 37-48.
53. Manca F, Habeshaw JA, Dalgleish AG. The naive repertoire of human T helper cells specific for HIV envelope glycoprotein gp120. J Immunol 1991; 146: 1964-1971.
54. Genevée C et al. An experimentally validated panel of subfamily-specific oligonucleotide primers for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992; 22: 1262-1269.
55. Choi Y et al. Interaction of Staphylococcus aureus toxin superantigens with human T cells. Proc Natl Acad Sci USA 1989; 86: 8941-8945.
56. Ferradini L et al. Studies on the human T cell receptor αβ variable region genes. Eur J Immunol 1991; 21: 935-942.
57. Gorski J et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. J Immunol 1994; 152: 5109-5119.
58. De Palma R, Gorski J. Restricted and conserved T cell repertoires involved in allorecognition of class II major histocompatibility complex. Proc Natl Acad Sci USA 1995; 92: 8836-8840.
59. Pannetier C, Even J, Kourilsky P. T cell repertoire diversity and clonal expansion in normal and clinical samples. Immunol Today 1995; 16: 176-181.
60. Pannetier C et al. The size of CDR3 hypervariable regions of the murine T cell receptor β chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993; 90: 4319-4323.
61. Ausiello CM et al. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans. Infect Immunol 1993; 61: 4105-4111.